-+ 0.00%
-+ 0.00%
-+ 0.00%

ICHNOS GLENMARK INNOVATION: SUBMITS IND APPLICATION TO FDA FOR ISB 2301, FIRST-IN-CLASS MULTISPECIFIC IMMUNE CELL ACTIVATOR

Reuters·11/17/2026 16:40:58

Please log in to view news